The American Trade Association for Cannabis and Hemp offered this statement following the FDA rejection of Charlotte’s Web CBD As Dietary Supplement: “The current regulatory landscape regarding CBD is untenable. CBD requires a clear regulatory pathway that provides meaningful oversight, and takes into account both the growing market as well as consumer public health and […]

Continue Reading

From BusinessWire.com Panel supports Company’s ongoing commitment to consumer-driven product development and innovation MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of the Cannabis Innovators Panel, a cannabis consumer panel offering real-time […]

Continue Reading

MORE Act Reintroduced in House Issue: Today, House Judiciary Committee Chairman Nadler (D-NY) re-introduced “The Marijuana Opportunity, Reinvestment and Expungement (MORE) Act.” Impact: The MORE Act would remove marijuana from under The Controlled Substances Act (CSA), create a Federal tax which would support community reinvestment, and expunge certain prior marijuana convictions. This version contains several […]

Continue Reading

President of The American Trade Association for Cannabis & Hemp (ATACH) Michael Bronstein joined Richard Carleton, CEO of the CSE – Canadian Securities Exchange for a conversation as part of the Cannabis Investor Series Episode 1: Investing in American Cannabis. You can catch the discussion here:

Continue Reading

ATACH honored the memory of Barrett Seller who played an important role in the founding of our organization. ATACH recognizes the bright light in Barrett that warmed and touched so many. Our thoughts are with Barrett and his family and today we remember the passion and leadership he brought to our organization. ATACH has presented […]

Continue Reading

Michael Bronstein, President, American Trade Association for Cannabis & Hemp offered the following statement following the passing of Steve Fox: “Steve Fox was a towering figure in the cannabis industry, the intellectual force behind many major policy changes, and a committed advocate who led and mentored a generation of advocates. Steve Fox’s loss is so […]

Continue Reading

Today, 101 years after the beginning of U.S. alcohol prohibition in 1920 and fresh off the heels of a national election that changed the political composition of the U.S. Senate and Executive Branch, the American Trade Association for Cannabis and Hemp (ATACH) announced the formation of ATACH’s Cannabis Beverage Council. The Council will bring together […]

Continue Reading

President-elect Joe Biden’s new pick for a leading role in the U.S. Department of Health and Human Services (HHS) is a strong ally of the medical marijuana community—the latest pro-reform selection to be named in recent weeks. Rachel Levine, who currently serves as Pennsylvania’s health secretary, is being nominated for assistant secretary of HHS. And […]

Continue Reading

“Dr. Rachel Levine is a trailblazer who successfully guided the implementation of Pennsylvania’s medical marijuana program. Under Dr. Levine’s leadership, the program expanded qualifying conditions based on science, added flower to help meet patient needs, and stood up a first in the nation marijuana research program. Pennsylvania is now one of the quickest growing and […]

Continue Reading

Join the Nevada Dispensary Association they we sit down with American Trade Association for Cannabis & Hemp (ATACH) Co-Founder, Michael Bronstein, to discuss the current state of federal cannabis policy. Mr. Bronstein will address banking, 280E, standards development, the federal framework and legislative outlook, and the impact of the Biden Administration on the future of cannabis policy. When: January 15th […]

Continue Reading